Ive been offered a new job, and I want to see how the cost of the new employers health care stacks up. How much does the average family pay for health care? What can I do to save money on health costs?
See Also: 5 Ways to Ease the Pain of Health Care Costs in Retirement
The majority of families still get health insurance through their employers, and the average cost of health care for a family of four with employer coverage is $25,826, according to the 2016 Milliman Medical Index. Thats a 4.7% increase in the past year and triple the cost in 2001, when Milliman first conducted the study and average health care costs were $8,414.
Employers still cover the bulk of the cost, paying an average of $14,793 while the employee pays $11,033, which includes the employees share of the premiums and out-of-pocket costs. Employees pay a larger share than in the past; they paid 39% of the total health care costs on average when Milliman first did the study in 2001. This year, their share accounts for 43% of the total.
Top 10 Medical Stocks For 2018: EchoStar Corporation(SATS)
Advisors’ Opinion:
- [By Max Byerly]
Teachers Advisors LLC grew its stake in shares of Echostar Co. (NASDAQ:SATS) by 9.2% in the fourth quarter, Holdings Channel reports. The fund owned 59,929 shares of the communications equipment provider’s stock after buying an additional 5,059 shares during the quarter. Teachers Advisors LLC’s holdings in Echostar were worth $3,590,000 at the end of the most recent reporting period.
- [By Shane Hupp]
Echostar Holding Corp (NASDAQ:SATS) reached a new 52-week high and low during mid-day trading on Friday . The company traded as low as $51.33 and last traded at $52.44, with a volume of 104714 shares trading hands. The stock had previously closed at $51.79.
- [By Lisa Levin] Companies Reporting Before The Bell
Nomad Foods Limited (NYSE: NOMD) is estimated to report quarterly earnings at $0.36 per share on revenue of $656.43 million.
AMC Networks Inc. (NASDAQ: AMCX) is expected to report quarterly earnings at $2.2 per share on revenue of $720.14 million.
Magna International Inc. (NYSE: MGA) is projected to report quarterly earnings at $1.7 per share on revenue of $10.11 billion.
Univar Inc. (NYSE: UNVR) is estimated to report quarterly earnings at $0.36 per share on revenue of $2.12 billion.
Duke Energy Corporation (NYSE: DUK) is expected to report quarterly earnings at $1.14 per share on revenue of $5.78 billion.
Owens & Minor, Inc. (NYSE: OMI) is projected to report quarterly earnings at $0.47 per share on revenue of $2.40 billion.
Prestige Brands Holdings, Inc. (NYSE: PBH) is expected to report quarterly earnings at $0.61 per share on revenue of $255.60 million.
Tribune Media Company (NYSE: TRCO) is projected to report quarterly earnings at $0.06 per share on revenue of $457.67 million.
ArcBest Corporation (NASDAQ: ARCB) is estimated to report quarterly loss at $0.07 per share on revenue of $691.18 million.
Genesis Healthcare, Inc. (NYSE: GEN) is projected to report quarterly loss at $0.34 per share on revenue of $1.32 billion.
Enbridge Inc. (NYSE: ENB) is expected to report quarterly earnings at $0.55 per share on revenue of $10.14 billion.
Kelly Services, Inc. (NASDAQ: KELYA) is estimated to report quarterly earnings at $0.42 per share on revenue of $1.34 billion.
NICE Ltd. (NASDAQ: NICE) is expected to report quarterly earnings at $1.01 per share on revenue of $332.93 million.
World Acceptance Corporation (NASDAQ: WRLD) is estimated to report quarterly earnings at $3.94 per share on revenue of $147.32 million.
MAXIMUS, Inc. (NYSE: MMS) is expected to report quarterly earnings at $0.84 per share on revenue of $616.04 million.
Choice Hotels International, Inc. (NYSE: CH
Top 10 Medical Stocks For 2018: REGENXBIO Inc.(RGNX)
Advisors’ Opinion:
- [By Stephan Byrd]
These are some of the news headlines that may have effected Accern Sentiment Analysis’s rankings:
Get REGENXBIO alerts:
Quant Scorecard Under Review For REGENXBIO Inc. (NasdaqGS:RGNX) (derbynewsjournal.com) Regenxbio Inc (RGNX) AroonUp Technicals Showing Momentum Building (parkcitycaller.com) Showing Signs of Life? Stock Update on REGENXBIO Inc. (NASDAQ:RGNX) (parkcitycaller.com) Relative Strength Index (RSI 14) to Watch Mueller Water Products, Inc. (NYSE:MWA), REGENXBIO Inc. (NASDAQ … (stocksnewspoint.com) Are You Looking For Opportunity on Stock? REGENXBIO Inc. (RGNX) (nysestocks.review)
A number of research firms have weighed in on RGNX. TheStreet upgraded REGENXBIO from a “d+” rating to a “c” rating in a research note on Friday, May 11th. ValuEngine upgraded REGENXBIO from a “hold” rating to a “buy” rating in a research note on Friday, May 11th. Raymond James set a $45.00 price objective on REGENXBIO and gave the company a “buy” rating in a research note on Tuesday, May 8th. Barclays reiterated an “overweight” rating and set a $48.00 price objective (up previously from $38.00) on shares of REGENXBIO in a research note on Wednesday, May 9th. Finally, BidaskClub upgraded REGENXBIO from a “hold” rating to a “buy” rating in a research note on Friday, April 20th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and eight have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $43.25.
- [By Jim Crumly]
For AveXis shareholders it was a big payday, and the deal boosted stocks of other companies in the gene therapy space, especially those of REGENXBIO (NASDAQ:RGNX), which is partnered with AveXis to provide the virus-based gene delivery technology for all of the company’s therapies. Shares of REGENXBIO soared 15.6% on the news.
Top 10 Medical Stocks For 2018: CNO Financial Group, Inc.(CNO)
Advisors’ Opinion:
- [By Shane Hupp]
Coin(O) (CURRENCY:CNO) traded flat against the U.S. dollar during the twenty-four hour period ending at 21:00 PM ET on May 12th. One Coin(O) coin can now be purchased for about $0.0021 or 0.00000025 BTC on popular exchanges. Coin(O) has a market cap of $222,284.00 and $40.00 worth of Coin(O) was traded on exchanges in the last 24 hours. Over the last seven days, Coin(O) has traded 21.2% lower against the U.S. dollar.
- [By ]
The Evercore analysts also said that Metlife Inc. (MET) and CNO Financial Group Inc. (CNO) have “sizable exposure” to long-term care from a reserve standpoint, “but our analysis indicates that their blocks have below average risk and/or more robust reserves versus peers, implying a lower risk of charges over the next few years.”
Top 10 Medical Stocks For 2018: Newmont Mining Corporation(NEM)
Advisors’ Opinion:
- [By Joseph Griffin]
Boston Partners boosted its holdings in shares of Newmont Mining Co. (NYSE:NEM) by 4.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 50,976 shares of the basic materials company’s stock after buying an additional 2,033 shares during the quarter. Boston Partners’ holdings in Newmont Mining were worth $1,992,000 at the end of the most recent quarter.
- [By Stephan Byrd]
Wilkins Investment Counsel Inc. lifted its stake in Newmont Mining Co. (NYSE:NEM) by 0.7% in the 1st quarter, Holdings Channel reports. The firm owned 359,285 shares of the basic materials company’s stock after acquiring an additional 2,550 shares during the period. Newmont Mining comprises about 4.4% of Wilkins Investment Counsel Inc.’s holdings, making the stock its 2nd biggest position. Wilkins Investment Counsel Inc.’s holdings in Newmont Mining were worth $14,037,000 at the end of the most recent reporting period.
- [By Ethan Ryder]
Engineers Gate Manager LP lessened its stake in shares of Newmont Mining Co. (NYSE:NEM) by 44.6% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 85,506 shares of the basic materials company’s stock after selling 68,807 shares during the period. Engineers Gate Manager LP’s holdings in Newmont Mining were worth $3,341,000 at the end of the most recent reporting period.
- [By Todd Campbell]
If these reasons have you interested in adding gold mining stocks to your portfolio, a few top companies to consider are Barrick Gold (NYSE:ABX), Randgold Resources (NASDAQ:GOLD), Newmont Mining (NYSE:NEM), Freeport McMoran (NYSE:FCX) and Goldcorp (NYSE:GG). All five could benefit if gold prices rally, so let’s learn more about them.
- [By Matthew DiLallo]
Barrick Gold is the largest gold miner in the world, producing 5.32 million ounces of the precious metal in 2017. While that was down from 5.53 million ounces in 2016 — and well off the company’s peak from a few years ago — it was enough to edge out Newmont Mining’s (NYSE:NEM) 5.27 million ounces for the top spot. In addition to gold, Barrick also produced 413 million pounds of copper, which — while significant — pales in comparison to Freeport-McMoRan’s 3.7 billion pounds, enough to make it the world’s largest publicly traded copper producer.
- [By ]
Gold miners have fought for their survival over the last several years, cutting new investments in production and trimming costs. Data from Bloomberg shows the average extraction costs at the largest miners has fallen 27% over the last five years. Tom Brady, Chief Economist at Newmont Mining (NYSE: NEM) estimates global gold production will slip by 1% annually over the next several years due to decreased capital spending by miners.
Top 10 Medical Stocks For 2018: Credit Acceptance Corporation(CACC)
Advisors’ Opinion:
- [By Logan Wallace]
Credit Acceptance (NASDAQ:CACC) last posted its earnings results on Thursday, May 3rd. The credit services provider reported $6.11 earnings per share for the quarter, missing the Zacks’ consensus estimate of $6.19 by ($0.08). The company had revenue of $295.60 million for the quarter, compared to analysts’ expectations of $296.16 million. Credit Acceptance had a net margin of 43.49% and a return on equity of 29.44%. The firm’s quarterly revenue was up 12.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $4.67 EPS. equities research analysts anticipate that Credit Acceptance will post 26.04 EPS for the current fiscal year.
Top 10 Medical Stocks For 2018: B Communications Ltd.(BCOM)
Advisors’ Opinion:
- [By Lisa Levin]
Monday afternoon, the telecommunication services shares climbed 0.69 percent. Meanwhile, top gainers in the sector included B Communications Ltd (NASDAQ: BCOM), up 5 percent, and China Unicom (Hong Kong) Limited (NYSE: CHU), up 3 percent.
Top 10 Medical Stocks For 2018: InterXion Holding N.V.(INXN)
Advisors’ Opinion:
- [By Stephan Byrd]
Interxion (NYSE:INXN) had its price objective boosted by Citigroup from $68.00 to $75.00 in a research note issued to investors on Friday morning. Citigroup currently has a buy rating on the technology company’s stock.
- [By Max Byerly]
Jacobson & Schmitt Advisors LLC lessened its holdings in shares of Interxion (NYSE:INXN) by 1.8% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 102,697 shares of the technology company’s stock after selling 1,927 shares during the quarter. Interxion comprises approximately 4.4% of Jacobson & Schmitt Advisors LLC’s portfolio, making the stock its 5th biggest holding. Jacobson & Schmitt Advisors LLC owned 0.14% of Interxion worth $6,378,000 at the end of the most recent quarter.
Top 10 Medical Stocks For 2018: Rexnord Corporation(RXN)
Advisors’ Opinion:
- [By Motley Fool Staff]
Rexnord Corporation (NYSE:RXN) Q4 2018 Earnings Conference CallMay. 15, 2018 8:00 a.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:Operator
- [By Lisa Levin]
Companies Reporting After The Bell
Agilent Technologies, Inc. (NYSE: A) is estimated to post quarterly earnings at $0.64 per share on revenue of $1.21 billion.
Vipshop Holdings Limited (NYSE: VIPS) is expected to post quarterly earnings at $0.18 per share on revenue of $3.10 billion.
Rexnord Corporation (NYSE: RXN) is projected to post quarterly earnings at $0.39 per share on revenue of $551.94 million.
Invitation Homes Inc. (NYSE: INVH) is estimated to post quarterly earnings at $0.03 per share on revenue of $423.13 million.
Switch, Inc. (NYSE: SWCH) is expected to post quarterly earnings at $0.05 per share on revenue of $99.83 million.
Itron, Inc. (NASDAQ: ITRI) is projected to post quarterly earnings at $0.13 per share on revenue of $579.85 million.
Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) is expected to post quarterly earnings at $0.44 per share on revenue of $119.06 million.
Amyris, Inc. (NASDAQ: AMRS) is estimated to post quarterly earnings at $0.07 per share on revenue of $68.14 million.
Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) is projected to post quarterly loss at $0.38 per share on revenue of $1.87 million.
VOXX International Corporation (NASDAQ: VOXX) is expected to post quarterly earnings at $0.05 per share on revenue of $130.00 million.
Phoenix New Media Limited (NYSE: FENG) is estimated to post quarterly loss at $0.12 per share on revenue of $45.38 million.
Restoration Robotics, Inc. (NASDAQ: HAIR) is projected to post quarterly loss at $0.17 per share on revenue of $5.93 million.
YogaWorks, Inc. (NASDAQ: YOGA) is estimated to post quarterly loss at $0.22 per share on revenue of - [By Joseph Griffin]
Rexnord (NYSE:RXN) announced its quarterly earnings results on Monday. The industrial products company reported $0.38 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.39 by ($0.01), reports. Rexnord had a net margin of 8.29% and a return on equity of 13.05%.
Top 10 Medical Stocks For 2018: Gaming and Leisure Properties, Inc.(GLPI)
Advisors’ Opinion:
- [By Lisa Levin]
Check out these big penny stock gainers and losers
Losers
Teradyne, Inc. (NYSE: TER) fell 10.8 percent to $37.02 in pre-market trading after the company issued downbeat Q2 guidance.
Edwards Lifesciences Corporation (NYSE: EW) fell 9.2 percent to $122.29 in pre-market trading. Edwards Lifesciences reported better-than-expected results for its first quarter, but issued weak earnings guidance for the second quarter.
New Gold Inc. (NYSE: NGD) fell 8.8 percent to $2.30 in pre-market trading after rising 4.13 percent on Tuesday.
Gold Fields Limited (ADR) (NYSE: GFI) fell 8.6 percent to $3.61 in pre-market trading.
Natus Medical Incorporated (NASDAQ: BABY) fell 8.2 percent to $32.95 in pre-market trading after the company issued weak forecast for the second quarter.
Atossa Genetics Inc. (NASDAQ: ATOS) shares fell 7.9 percent to $3.50 in pre-market trading after climbing 27.09 percent on Tuesday.
Bright Scholar Education Holdings Limited (NYSE: BEDU) shares fell 6.7 percent to $13.58 in pre-market trading after reporting Q1 results.
Sangamo Therapeutics Inc (NASDAQ: SGMO) fell 5.9 percent to $16.75 in pre-market trading following announcement of a $200 million common stock offering.
Foresight Autonomous Holdings Ltd (NASDAQ: FRSX) shares fell 5.7 percent to $3.29 in pre-market trading after declining 3.32 percent on Tuesday.
Euronav NV (NYSE: EURN) fell 4.8 percent to $8.40 in pre-market trading.
Limelight Networks, Inc. (NASDAQ: LLNW) shares fell 4.3 percent to $4.69 in pre-market trading.
Gaming and Leisure Properties Inc (NASDAQ: GLPI) shares fell 4.1 percent to $32.92 in pre-market trading after the company issued downbeat quarterly results and reported the retirement of CFO William Clifford - [By Travis Hoium]
Penn National was the first major gaming company to launch a real estate investment trust, aka a REIT, known as Gaming and Leisure Properties Inc (NASDAQ:GLPI). The REIT has acquired most of Penn National Gaming’s real estate along with the real estate of Pinnacle Entertainment and other gaming companies as well.
- [By Rich Duprey]
Billionaire investor Carl Icahn is all but exiting the casino industry, selling his stake in Tropicana Entertainment for $1.85 billion. But maybe Eldorado Resorts (NASDAQ:ERI)– which will operate the properties bought by real estate investment trust (REIT)Gaming & Leisure Properties (NASDAQ:GLPI)– shouldn’t be going all in.
Top 10 Medical Stocks For 2018: Smart(SFS)
Advisors’ Opinion:
- [By Shane Hupp]
Smart & Final (NYSE: SFS) and Kroger (NYSE:KR) are both consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.
- [By Lisa Levin]
Losers
Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
Arcadia Biosciences, Inc. (N
